ADIPOPHARMA
Description:
- New peptide drug candidates to treat patients with insulin-resistant type 2 diabetes.
- AdipoPharma offers patients a much more flexible, effective treatment with fewer side effects.
At the origin of the project
- Vincent MARION, Institut de Génétique Médicale de Strasbourg / University of Strasbourg, INSERM UMRS 1112, Federation of Translational Medicine of Strasbourg